Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Cebranopadol

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024

    03 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240903523518/en

    BUSINESSWIRE
    03 Sep 2024
    Share Share
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol

    22 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240821421996/en

    BUSINESSWIRE
    22 Aug 2024
    Share Share
    Tris Pharma Presents Data On Cebranopadol For Pain Treatment
    Tris Pharma Presents Data On Cebranopadol For Pain Treatment

    06 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240805194778/en

    BUSINESSWIRE
    06 Aug 2024
    Share Share
    Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress
    Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730108785/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share
    Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Cebranopadol
    Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Cebranopadol

    05 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230905720896/en

    BUSINESSWIRE
    05 Sep 2023
    Share Share
    Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH'S Cebranopadol
    Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH'S Cebranopadol

    28 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230828282884/en

    BUSINESSWIRE
    28 Aug 2023
    Share Share